EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Special Issue “Stem Cell Biology & Regenerative Medicine”

Rivka Ofir iD

International Journal of Molecular Sciences · 16.08.2023 · 24 (16) · 12855

DOI: 10.3390/ijms241612855 ↗

Kurz gefasst

Editorial in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.08.2023. Verfasst von Rivka Ofir. Beteiligte Einrichtung: BGU-iPSC Core Facility, The Regenerative Medicine & Stem Cell (RMSC) Research Center, Ben Gurion University of the Negev, Israel and Desert & Dead Se…. Hauptthemen laut MEDLINE: Regenerative Medicine, Drug Discovery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

More than 50% of pre-clinical studies fail despite a long and expensive journey of drug discovery using animal models [...]

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Regenerative MedicineDrug DiscoveryAnimalsModels, Animal

Autor:innen und Institutionen

  • BGU-iPSC Core Facility, The Regenerative Medicine & Stem Cell (RMSC) Research Center, Ben Gurion University of the Negev, Israel and Desert & Dead Sea R&D, Central Arava Branch, Be'er Sheva 84105, Israel.

ORCID-Profile: Rivka Ofir

Zitieren

APA

Ofir, R. (2023). Special Issue “Stem Cell Biology & Regenerative Medicine”. International Journal of Molecular Sciences, 24(16), 12855. https://doi.org/10.3390/ijms241612855

Vancouver

Ofir R. Special Issue “Stem Cell Biology & Regenerative Medicine”. International Journal of Molecular Sciences. 2023;24(16):12855. doi:10.3390/ijms241612855

BibTeX
@article{Ofir2023,
  author = {Ofir, Rivka},
  title = {Special Issue “Stem Cell Biology & Regenerative Medicine”},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {16},
  pages = {12855},
  doi = {10.3390/ijms241612855}
}
Kostenlos starten →